Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness [NA]

View source ↗

Summary

Clinical trial update on Pycnogenol (French maritime pine bark extract) for Gulf War illness. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pycnogenol (French maritime pine bark extract (Pinus pinaster bark extract))

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Gulf War Syndrome | NA | Status: NOT_YET_RECRUITING